#CIN2

[nicknotes2]

Rasmus Klaos

[undies-4-life]

28-November 2023: The First Underwear Haul

I went a bit crazy with underwear purchases over the Black Friday weekend. Here is the first batch from C-in2. I am expecting more from Todd Sanfield and Jack Adams. I spent just over $500! Tell me I don't have a problem with underwear addiction?!? Oh boy!

What did you buy? Show me your undies!

[undies-4-life]

22-October 2023: Cin2 Trunks

I’m wearing purple today even though the Vikings don’t play until tomorrow. This pair really highlights the bulge nicely!

Which of your pairs shows off your assets? Show me your undies!

[undies-4-life]

24-September 2023: Thonging it for the Vikings!

It’s been hard watching the Minnesota Vikings lose 3 in a row this season. I wore purple to support the team, but it didn’t work. I don’t often wear thongs due to the pressure they exert in the nether region. Now watching the boys lose, it’s like I’m getting f”@&ed twice. 😈

What are you wearing? Show me your undies! And if you want to see the backside, check out the blog link below.

[theprojectfabulosity]

Be Your Own Muse Series ~ Chelsea, NY 8.29.23

Jeremiah Project Fabulosity

#BeYourOwnMuseSeries

Music Ref George Kopaliani This is Love

[nicknotes2]

Dominic Calvani

[nicknotes2]

Jared P. Smith

[nicknotes2]

Mike Monroe [dna]

[nicknotes2]

Nick Boisseau

[nicknotes2]

Anton Lapidus

[darkmaga-returns]

The CDC’s Manipulation of HPV Vaccine Data

The Centers for Disease Control and Prevention (CDC) has long positioned itself as the ultimate authority on public health, a beacon of science-driven policymaking. Yet, when it comes to the human papillomavirus (HPV) vaccine, or any vaccine, for that matter, the agency’s commitment to scientific rigor is increasingly compromised. The most recent Morbidity and Mortality Weekly Report (MMWR) proclaims dramatic reductions in cervical intraepithelial neoplasia (CIN2+ and CIN3+) following the widespread administration of HPV vaccines. The CDC attributes these declines unequivocally to vaccination, crafting a narrative that frames the vaccine as an undeniable triumph of modern medicine.

This report, however, follows a familiar pattern—the deliberate exclusion of data that could complicate the preferred conclusion. Nowhere in the CDC’s analysis does one find any discussion of HPV type replacement, a well-documented phenomenon in which non-vaccine HPV types increase in prevalence following the suppression of vaccine-targeted strains. Despite independent studies confirming post-vaccine increases in HPV31, HPV33, HPV52, and HPV58, the CDC’s surveillance system has systematically avoided tracking these trends. If they were truly confident that type replacement was not occurring, they would conduct routine genotyping to prove it; instead, their refusal to do so suggests they already suspect the answer.

There is no mention of shifting type frequency or co-infection dynamics, where rarer, potentially more oncogenic HPV types may gain dominance in vaccinated populations due to altered competitive exclusion. The report is similarly devoid of any acknowledgment of the failure to demonstrate direct reductions in invasive cervical cancer, the ultimate endpoint that matters in determining whether the vaccine fulfills its intended purpose.